Christian Henrik Tange
Directeur/Membre du Conseil chez KDev Investments AB
Postes actifs de Christian Henrik Tange
Sociétés | Poste | Début | Fin |
---|---|---|---|
KDev Investments AB
KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Christian Henrik Tange
Anciens postes connus de Christian Henrik Tange
Sociétés | Poste | Début | Fin |
---|---|---|---|
AGILLIC A/S | Directeur Financier/CFO | 01/04/2018 | 01/09/2020 |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Directeur Financier/CFO | 01/02/2014 | 30/11/2017 |
KAROLINSKA DEVELOPMENT AB | Directeur Financier/CFO | 01/01/2014 | 29/08/2017 |
AGC Biologics A/S
AGC Biologics A/S Pharmaceuticals: MajorHealth Technology AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark. | Directeur Financier/CFO | 01/01/2003 | - |
Warner Lambert Nordic AB | Corporate Officer/Principal | 01/01/1997 | - |
PROMIMIC AB | Directeur/Membre du Conseil | - | - |
XSPRAY PHARMA AB | Directeur/Membre du Conseil | - | - |
KDev Oncology AB
KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Directeur/Membre du Conseil | - | - |
░░░░░░░ ░░ | ░░░░░░░░ | - | - |
Formation de Christian Henrik Tange
Copenhagen Business School | Graduate Degree |
Statistiques
Internationale
Suède | 8 |
Danemark | 4 |
Norvège | 2 |
Opérationnelle
Director of Finance/CFO | 4 |
Director/Board Member | 4 |
Graduate Degree | 1 |
Sectorielle
Health Technology | 6 |
Finance | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
KAROLINSKA DEVELOPMENT AB | Finance |
XSPRAY PHARMA AB | Health Technology |
PROMIMIC AB | Health Technology |
AGILLIC A/S | Technology Services |
Entreprise privées | 6 |
---|---|
AGC Biologics A/S
AGC Biologics A/S Pharmaceuticals: MajorHealth Technology AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark. | Health Technology |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Finance |
Warner Lambert Nordic AB | |
KDev Investments AB
KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Health Technology |
Dilafor AB
Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Health Technology |
KDev Oncology AB
KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Commercial Services |
- Bourse
- Insiders
- Christian Henrik Tange
- Expérience